AXIOS January 3, 2023
Oriana Gonzalez

The Food and Drug Administration on Tuesday made a regulatory change that will make it possible for retail pharmacies to offer abortion pills in the U.S., Axios has confirmed.

The big picture: Under the regulatory change, certified pharmacies may dispense mifepristone — which is used with misoprostol in first-trimester abortions — directly to patients after receiving a prescription from a certified health provider, according to a statement from Danco Laboratories, one of the makers of the pill.

  • The FDA has yet to make an announcement, but the agency is expected to update its website to reflect the change later Tuesday.
  • The New York Times first reported the news.

State of play: Mifepristone is approved by the FDA in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Pharma, Pharma / Biotech, Provider
New 'how-to guide' for future rapid vaccine development
Infographic: R&D Spending Growth of Top Pharma Companies
Medicare prescription drug pricing variance: 5 things to know
Adoption Of Model-Informed Drug Development Can Improve Pharma ROI
Sanofi adds new $600M manufacturing plant

Share This Article